February 2026
The global digital therapeutics for mental health market size was estimated at USD 3.74 billion in 2025 and is predicted to increase from USD 4.51 billion in 2026 to approximately USD 24.42 billion by 2035, expanding at a CAGR of 20.64% from 2026 to 2035.
The digital therapeutics for mental health market is growing as it offers accessibility, convenience, and confidentiality, real-time monitoring and data, it reduces risk and side effects, and enhances outcomes.
| Key Elements | Scope |
| Market Size in 2026 | USD 4.51 Billion |
| Projected Market Size in 2035 | USD 24.42 Billion |
| CAGR (2026 - 2035) | 20.64% |
| Leading Region | North America |
| Market Segmentation | By Product Type, By Application, By End User, By Distribution Channel, By Regional Insight |
| Top Key Players | BigHealth, Akili Interactive Labs, Inc., Woebot Health, Inc., Mindstrong Health, Inc., Cognoa, Inc., SilverCloud Health Ltd., Livongo Health, Inc. |
The integration of AI-based technology into the market is growing as AI-driven technology has transformed this domain by allowing acceptable, data-based interventions that cater to patients' requirements, ranging from mood disorders to challenging conditions such as post-traumatic stress disorder (PTSD) and depression. AI-based solutions leverage machine learning models to analyse end-user data, like mood patterns, behavioural indicators, and physiological signals, to offer tailored recommendations and real-time responses.
Digital companions provide the opportunity for more targeted and personalized strategies to medical care, leveraging data, analytics, and AI/ML algorithms to bring evidence-driven interventions tailored to the patient's particular needs.
Virtual reality (VR) is a significantly powerful technology for improving assessment in mental health. It is an efficient process of rehabilitation for patients with different phobias, Parkinson's disease, anxiety disorders, Alzheimer's disease, multiple sclerosis, depression, PTSD, and insomnia.
Hybrid care models integrate traditional face-to-face or telehealth schedules with the use of digital tools, like smartphone applications, digital therapeutics, or wearable devices, to improve and target care delivery.
Which Product Type Led the Digital Therapeutics for Mental Health Market in 2024?
In 2025, the software-based digital therapeutics segment held the dominant market, as digital treatments apply software to train or enhance symptoms in patients outside of cognitive‐driven therapies and conventional therapies; this also comprised the collection of information in a patient portal for the patient to access and receive guidance for the next step of their treatment plan. Digital therapeutics function by using software as an apparatus to directly influence patient behaviour and health outcomes.
Hardware-Based Digital Therapeutics
Whereas the hardware-based digital therapeutics segment is the fastest-growing in the market, as hardware-based digital strategies in cognitive behavioural therapy offer advantages similar to patient care with a positive effect on symptoms such as fatigue, depression, and anxiety. Digital therapeutics are progressively used to treat conditions such as anxiety, depression, PTSD, and substance use disorders.
Why did the Depression Segment Dominate the Market in 2024?
The depression segment is dominant in the digital therapeutics for mental health market in 2025, as it is accessible via smartphones or computers and teaches patients novel skills and habits to support them in regulating depression. Digital therapeutics provides a gifted and ground-breaking strategy to managing anxiety and depression, with the potential to improve affordability, accessibility, and patient engagement in mental health care.
Post-Traumatic Stress Disorder (PTSD)
Whereas the post-traumatic stress disorder (PTSD) segment is the fastest growing in the market, as digital therapeutics apply software-based interventions, like mindfulness exercises, VR exposure therapy, and CBT modules, to tackle PTSD symptoms. These tools are often delivered through mobile apps or online platforms, making them convenient and consumer-friendly. Digital therapeutics provides numerous benefits, including accessibility, personalization, and evidence-driven interventions.
Why is the Healthcare Providers Segment Dominant in the Market
In 2025, the healthcare providers segment held the dominant digital therapeutics for mental health market share, as digital therapeutics are rising to a new level by adding flexibility in location, time, and reach to patients. Therapy is obtainable straight to patients, avoiding lengthy support processes and shortages of therapists. Therapy is delivered through smartphones or wearable devices, making it more accessible and mobile than traditional medication.
Corporations
Whereas the corporations segment is the fastest growing in the market, as digital therapeutics have wonderful potential to lower disease burdens, deliver advanced clinical results, support providers to make more informed treatment decisions, and enhance patients’ lives by providing better ways to manage chronic health situations. Digital therapeutics have the potential to show techniques in treatment that give amplified patient access, lower side effects, and reduced challenges of addiction.
Why is the Adult Segment Dominant in the Market
In 2025, the direct-to-consumer segment held the dominant segment in the digital therapeutics for mental health market, as consumers manage chronic or stigmatized conditions such as sexual health, mental health, or addiction discreetly from a hub, bypassing the requirement for in-person hospital visits. DTC platforms allow pharma to set and communicate costs clearly, a strategic benefit as MFN rules drive for international price equality.
Third-Party Platforms
Whereas the third-party platforms segment is the fastest growing in the market, as digital therapeutics have wonderful potential to reduce disease challenges, deliver advanced clinical results, support providers in making more well-versed treatment decisions, and enhance patients’ lives by providing better ways to achieve chronic health conditions. Digital therapeutics provides incumbents access to novel sections of the healthcare value chain and a method to play in the much larger end-to-end medical care.
| Mental Health Challenges Patients | Percentages of Patients |
| Adult | 20.4% |
| Women | 24.3% |
| Men | 15.5% |
In 2025, North America led the digital therapeutics for mental health market, with a progressive medical care infrastructure, strong government frameworks, and high digital acceptance. Approximately 1 in 5 American adults will have a diagnosable mental health situation in 2024. 46% of Americans meet the criteria for a diagnosable mental health condition sometime in their life, which raises the demand for digital therapeutics for mental health solutions.
For Instance,
Increasing acceptance of digital technology, for instance, in 2025, more than 93.1% of North Americans use the internet, that’s 332 million people. 92% of people have adopted a smartphone, and 9.9% use only that smartphone to connect to the internet, which increases the growth of digital therapeutics.
Asia Pacific is set to experience rapid growth in the digital therapeutics for mental health market, as this region has massive potential to tailor production and commercial AI-driven technology applications to residents' requirements. Individual countries within the Asia-Pacific region have distinct AI-driven technology capabilities and strengths. AI-based development initiatives are quickly spreading in countries in the Asia Pacific because of the emergence of related infrastructure and supportive country-specific guidelines.
India Market Trends
India's quick development in artificial intelligence, underpinned by strategic government initiatives, has positioned the country as a global AI-driven powerhouse. By increasing AI-based compute infrastructure, fostering indigenous AI models, improving digital public infrastructure, and investing in talent development, India is making an inclusive and innovation-based ecosystem.
Europe is experiencing substantial growth in its digital therapeutics for mental health market, as Europe’s advancement is deeply intertwined with its rich history, starting with early civilizations such as Greece and Rome. Increasing government support and infrastructure that continues to influence modern societies. Europe's high-tech sectors avoid complete marginalization. The EU has accepted a geopolitical strategy of financial statecraft.
UK Market Trends
In the UK, over 3.7 million people accessed mental health support through England’s NHS in 2023-2024, representing nearly a 40% rise since before the pandemic. As demand for mental health services increases more rapidly than the available resources, the UK faces a pressing need for solutions that are effective, accessible, scalable, and cost-efficient. Mental health services nationwide are under considerable strain, with demand surpassing existing resources.
For Instance,
| Diseases | Percentages |
| Depressive disorder | 39% |
| Anxiety disorder | 22% |
| Schizophrenia | 14% |
| Other mental disorders | 8% |
| Idiopathic developmental intellectual disability | 6% |
| Conduct disorder | 5% |
| Autism spectrum disorders | 3% |
| Eating disorder | 2% |
| Attention-deficit hyperactivity disorder | 1% |
| Company | Headquarters | Latest Update |
| BigHealth | United States | In March 2025, a New JAMA study showcases the clinical benefits of SleepioRx in patients with comorbid insomnia and depression symptoms. |
| Akili Interactive Labs, Inc. | United States | Akili Interactive, a leader in digital medicine, is to become publicly traded through a combination with social capital Surrey Holdings Corp. |
| Woebot Health, Inc. | United States | In June 2025, Woebot Health shut down its CBT-based therapy chatbot after informing users that conversation history would remain available for download through that date, and that personal data would be anonymized. |
| Mindstrong Health, Inc. | United States | In November 2025, Mindstrong raised $174M in funding from investors like General Catalyst, Bezos Expeditions, and Arch Venture Partners, with a last known valuation of $660M. |
| Cognoa, Inc. | Texas | Cognoa is an early childhood development and pediatric behavioral health company developing digital diagnostics and therapeutics. |
| SilverCloud Health Ltd. | Ireland | SilverCloud Health is the world’s leading digital mental health company, enabling healthcare organizations to deliver clinically validated digital therapeutic care. |
| Livongo Health, Inc. | United States | The Livongo brand name is being retired, and users are guided to transition their accounts to the Teladoc Health platform to access their existing programs and data. |
By Product Type
By Application
By End User
By Distribution Channel
By Regional Insight
February 2026
February 2026
February 2026
February 2026
sales@towardshealthcare.com
+1 804-441-9344
